KAYLYN AMUSO: Open Payments
NPI 1386206365 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,419 in 179 payments from 18 companies in 2025. Trend: 2023 $723 · 2024 $1,959 · 2025 $3,419
Food & beverage: $3,419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $720 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $452 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $417 |
| Lilly USA, LLC | 17 | $319 |
| Madrigal Pharmaceuticals | 5 | $311 |
| Janssen Biotech, Inc. | 12 | $269 |
| GENZYME CORPORATION | 4 | $145 |
| QOL Medical, LLC | 7 | $142 |
| Ipsen Biopharmaceuticals, Inc | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
Products named: XIFAXAN, ENTYVIO, RINVOQ, REZDIFFRA, OMVOH, TREMFYA, DUPIXENT, LINZESS.
Industry payments across NY — which companies pay providers there.
